Gujarat Themis Biosyn Ltd
BSE:506879
Gujarat Themis Biosyn Ltd
Accounts Receivables
Gujarat Themis Biosyn Ltd
Accounts Receivables Peer Comparison
Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Gujarat Themis Biosyn Ltd
BSE:506879
|
Accounts Receivables
₹227.9m
|
CAGR 3-Years
9%
|
CAGR 5-Years
32%
|
CAGR 10-Years
27%
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Accounts Receivables
₹80.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Accounts Receivables
₹47.7B
|
CAGR 3-Years
11%
|
CAGR 5-Years
3%
|
CAGR 10-Years
11%
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Accounts Receivables
₹113B
|
CAGR 3-Years
6%
|
CAGR 5-Years
4%
|
CAGR 10-Years
14%
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Accounts Receivables
₹52.2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
6%
|
CAGR 10-Years
16%
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Accounts Receivables
₹17.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
See Also
What is Gujarat Themis Biosyn Ltd's Accounts Receivables?
Accounts Receivables
227.9m
INR
Based on the financial report for Dec 31, 2023, Gujarat Themis Biosyn Ltd's Accounts Receivables amounts to 227.9m INR.
What is Gujarat Themis Biosyn Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
27%
Over the last year, the Accounts Receivables growth was -2%. The average annual Accounts Receivables growth rates for Gujarat Themis Biosyn Ltd have been 9% over the past three years , 32% over the past five years , and 27% over the past ten years .